Global (United States, European Union and China) Communicable Diseases Drugs Market Research Report 2019-2025
SKU ID :QYR-13724598 | Published Date: 26-Jul-2019 | No. of pages: 111Description
TOC
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Communicable Diseases Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 HIV
1.3.3 Influenza
1.3.4 TB
1.3.5 Malaria
1.3.6 Hepatitis
1.3.7 HPV
1.4 Market Segment by Application
1.4.1 Global Communicable Diseases Drugs Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Communicable Diseases Drugs Market Size
2.1.1 Global Communicable Diseases Drugs Revenue 2014-2025
2.1.2 Global Communicable Diseases Drugs Sales 2014-2025
2.2 Communicable Diseases Drugs Growth Rate by Regions
2.2.1 Global Communicable Diseases Drugs Sales by Regions 2014-2019
2.2.2 Global Communicable Diseases Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Communicable Diseases Drugs Sales by Manufacturers
3.1.1 Communicable Diseases Drugs Sales by Manufacturers 2014-2019
3.1.2 Communicable Diseases Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Communicable Diseases Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Communicable Diseases Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Communicable Diseases Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Communicable Diseases Drugs Price by Manufacturers
3.4 Key Manufacturers Communicable Diseases Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Communicable Diseases Drugs Market
3.6 Key Manufacturers Communicable Diseases Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 HIV Sales and Revenue (2014-2019)
4.1.2 Influenza Sales and Revenue (2014-2019)
4.1.3 TB Sales and Revenue (2014-2019)
4.1.4 Malaria Sales and Revenue (2014-2019)
4.1.5 Hepatitis Sales and Revenue (2014-2019)
4.1.6 HPV Sales and Revenue (2014-2019)
4.2 Global Communicable Diseases Drugs Sales Market Share by Type
4.3 Global Communicable Diseases Drugs Revenue Market Share by Type
4.4 Communicable Diseases Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Communicable Diseases Drugs Sales by Application
6 United States
6.1 United States Communicable Diseases Drugs Breakdown Data by Company
6.2 United States Communicable Diseases Drugs Breakdown Data by Type
6.3 United States Communicable Diseases Drugs Breakdown Data by Application
7 European Union
7.1 European Union Communicable Diseases Drugs Breakdown Data by Company
7.2 European Union Communicable Diseases Drugs Breakdown Data by Type
7.3 European Union Communicable Diseases Drugs Breakdown Data by Application
8 China
8.1 China Communicable Diseases Drugs Breakdown Data by Company
8.2 China Communicable Diseases Drugs Breakdown Data by Type
8.3 China Communicable Diseases Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Communicable Diseases Drugs Breakdown Data by Company
9.2 Rest of World Communicable Diseases Drugs Breakdown Data by Type
9.3 Rest of World Communicable Diseases Drugs Breakdown Data by Application
9.4 Rest of World Communicable Diseases Drugs Breakdown Data by Countries
9.4.1 Rest of World Communicable Diseases Drugs Sales by Countries
9.4.2 Rest of World Communicable Diseases Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.1.4 Communicable Diseases Drugs Product Introduction
10.1.5 Novartis Recent Development
10.2 Gilead
10.2.1 Gilead Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.2.4 Communicable Diseases Drugs Product Introduction
10.2.5 Gilead Recent Development
10.3 GSK
10.3.1 GSK Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.3.4 Communicable Diseases Drugs Product Introduction
10.3.5 GSK Recent Development
10.4 Janssen Pharmaceutical
10.4.1 Janssen Pharmaceutical Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.4.4 Communicable Diseases Drugs Product Introduction
10.4.5 Janssen Pharmaceutical Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.5.4 Communicable Diseases Drugs Product Introduction
10.5.5 Roche Recent Development
10.6 BioCryst Pharmaceuticals
10.6.1 BioCryst Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.6.4 Communicable Diseases Drugs Product Introduction
10.6.5 BioCryst Pharmaceuticals Recent Development
10.7 Merck
10.7.1 Merck Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.7.4 Communicable Diseases Drugs Product Introduction
10.7.5 Merck Recent Development
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.8.4 Communicable Diseases Drugs Product Introduction
10.8.5 Boehringer Ingelheim Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Communicable Diseases Drugs Sales Channels
11.2.2 Communicable Diseases Drugs Distributors
11.3 Communicable Diseases Drugs Customers
12 Market Forecast
12.1 Global Communicable Diseases Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Communicable Diseases Drugs Sales Forecast by Type
12.3 Global Communicable Diseases Drugs Sales Forecast by Application
12.4 Communicable Diseases Drugs Forecast by Regions
12.4.1 Global Communicable Diseases Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Communicable Diseases Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Communicable Diseases Drugs Product Picture
Table Communicable Diseases Drugs Key Market Segments
Table Major Manufacturers Communicable Diseases Drugs Covered in This Report
Table Global Communicable Diseases Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Communicable Diseases Drugs Sales Market Shar by Type 2014-2025
Figure HIV Figures
Table Major Manufacturers of HIV
Figure Influenza Figures
Table Major Manufacturers of Influenza
Figure TB Figures
Table Major Manufacturers of TB
Figure Malaria Figures
Table Major Manufacturers of Malaria
Figure Hepatitis Figures
Table Major Manufacturers of Hepatitis
Figure HPV Figures
Table Major Manufacturers of HPV
Table Global Communicable Diseases Drugs Market Share by Application 2019-2025 (K Units)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Other Use Case
Figure Communicable Diseases Drugs Report Years Considered
Figure Global Communicable Diseases Drugs Market Size 2014-2025 (Million US$)
Figure Global Communicable Diseases Drugs Sales 2014-2019 (K Units)
Table Global Communicable Diseases Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Communicable Diseases Drugs Sales by Regions 2014-2019 (K Units)
Table Global Communicable Diseases Drugs Sales Market Share by Regions 2014-2019
Figure Global Communicable Diseases Drugs Sales Market Share by Regions 2014-2019
Figure Global Communicable Diseases Drugs Sales Market Share by Regions in 2019
Table Global Communicable Diseases Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Communicable Diseases Drugs Revenue Market Share by Regions 2014-2019
Figure Global Communicable Diseases Drugs Revenue Market Share by Regions 2014-2019
Figure Global Communicable Diseases Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Communicable Diseases Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Communicable Diseases Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Communicable Diseases Drugs Sales Share by Manufacturers in 2019
Table Communicable Diseases Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Communicable Diseases Drugs Revenue Share by Manufacturers (2014-2019)
Figure Communicable Diseases Drugs Value Share by Manufacturers in 2019
Table Global Communicable Diseases Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Communicable Diseases Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Communicable Diseases Drugs Plants/Factories Distribution
Table Key Manufacturers Communicable Diseases Drugs Area Served
Table Date of Key Manufacturers Enter into Communicable Diseases Drugs Market
Table Key Manufacturers Communicable Diseases Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global HIV Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Influenza Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global TB Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Malaria Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Hepatitis Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global HPV Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Communicable Diseases Drugs Sales by Type (2014-2019) (K Units)
Table Global Communicable Diseases Drugs Sales Share by Type (2014-2019)
Figure Global Communicable Diseases Drugs Sales Market Share by Type (2014-2019)
Figure Global Communicable Diseases Drugs Sales Market Share by Type in 2018
Table Global Communicable Diseases Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Communicable Diseases Drugs Revenue Share by Type (2014-2019)
Figure Global Communicable Diseases Drugs Revenue Market Share by Type (2014-2019)
Figure Global Communicable Diseases Drugs Revenue Market Share by Type in 2018
Table Communicable Diseases Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Communicable Diseases Drugs Sales by Application (2014-2019) (K Units)
Table Global Communicable Diseases Drugs Sales Share by Application (2014-2019)
Figure Global Sales Communicable Diseases Drugs Market Share by Application (2014-2019)
Figure Global Sales Communicable Diseases Drugs Market Share by Application (2014-2019)
Figure United States Communicable Diseases Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Communicable Diseases Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Communicable Diseases Drugs Sales by Company (2014-2019) (K Units)
Table United States Communicable Diseases Drugs Sales Market Share by Company (2014-2019)
Figure United States Communicable Diseases Drugs Sales Market Share by Company in 2019
Table United States Communicable Diseases Drugs Sales by Type (2014-2019) (K Units)
Table United States Communicable Diseases Drugs Sales Market Share by Type (2014-2019)
Figure United States Communicable Diseases Drugs Market Share by Type in 2019
Table United States Communicable Diseases Drugs Sales by Application (2014-2019) (K Units)
Table United States Communicable Diseases Drugs Sales Market Share by Application (2014-2019)
Figure United States Communicable Diseases Drugs Market Share by Application in 2019
Figure European Union Communicable Diseases Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Communicable Diseases Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Communicable Diseases Drugs Sales by Company (2014-2019) (K Units)
Table European Union Communicable Diseases Drugs Sales Market Share by Company (2014-2019)
Figure European Union Communicable Diseases Drugs Sales Market Share by Company in 2019
Table European Union Communicable Diseases Drugs Sales by Type (2014-2019) (K Units)
Table European Union Communicable Diseases Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Communicable Diseases Drugs Market Share by Type
Table European Union Communicable Diseases Drugs Sales by Application (2014-2019) (K Units)
Table European Union Communicable Diseases Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Communicable Diseases Drugs Market Share by Application
Figure China Communicable Diseases Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Communicable Diseases Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Communicable Diseases Drugs Sales by Company (2014-2019) (K Units)
Table China Communicable Diseases Drugs Sales Market Share by Company (2014-2019)
Figure China Communicable Diseases Drugs Sales Market Share by Company in 2019
Table China Communicable Diseases Drugs Sales by Type (2014-2019) (K Units)
Table China Communicable Diseases Drugs Sales Market Share by Type (2014-2019)
Figure China Communicable Diseases Drugs Market Share by Type in 2019
Table China Communicable Diseases Drugs Sales by Application (2014-2019) (K Units)
Table China Communicable Diseases Drugs Sales Market Share by Application (2014-2019)
Figure China Communicable Diseases Drugs Market Share by Application in 2019
Figure Rest of World Communicable Diseases Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Communicable Diseases Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Communicable Diseases Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Communicable Diseases Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Communicable Diseases Drugs Sales Market Share by Company in 2019
Table Rest of World Communicable Diseases Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Communicable Diseases Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Communicable Diseases Drugs Market Share by Type in 2019
Table Rest of World Communicable Diseases Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Communicable Diseases Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Communicable Diseases Drugs Market Share by Application in 2019
Table Rest of World Communicable Diseases Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Communicable Diseases Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Communicable Diseases Drugs Sales Market Share by Countries in 2019
Table Rest of World Communicable Diseases Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Communicable Diseases Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Communicable Diseases Drugs Revenue Market Share by Countries in 2019
Figure Japan Communicable Diseases Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Communicable Diseases Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Communicable Diseases Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Communicable Diseases Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Communicable Diseases Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Communicable Diseases Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Communicable Diseases Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Communicable Diseases Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Novartis Communicable Diseases Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Gilead Company Details
Table Gilead Description and Business Overview
Table Gilead Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Gilead Communicable Diseases Drugs Sales Market Share in Global Market
Table Gilead Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table GSK Communicable Diseases Drugs Sales Market Share in Global Market
Table GSK Recent Development
Table Janssen Pharmaceutical Company Details
Table Janssen Pharmaceutical Description and Business Overview
Table Janssen Pharmaceutical Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceutical Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Janssen Pharmaceutical Communicable Diseases Drugs Sales Market Share in Global Market
Table Janssen Pharmaceutical Recent Development
Table Roche Company Details
Table Roche Description and Business Overview
Table Roche Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Roche Communicable Diseases Drugs Sales Market Share in Global Market
Table Roche Recent Development
Table BioCryst Pharmaceuticals Company Details
Table BioCryst Pharmaceuticals Description and Business Overview
Table BioCryst Pharmaceuticals Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioCryst Pharmaceuticals Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table BioCryst Pharmaceuticals Communicable Diseases Drugs Sales Market Share in Global Market
Table BioCryst Pharmaceuticals Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Merck Communicable Diseases Drugs Sales Market Share in Global Market
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Communicable Diseases Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Communicable Diseases Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Communicable Diseases Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Figure Communicable Diseases Drugs Value Chain
Table Communicable Diseases Drugs Distributors List
Table Communicable Diseases Drugs Customers List
Table Global Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Communicable Diseases Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Communicable Diseases Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Communicable Diseases Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Communicable Diseases Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Communicable Diseases Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure China Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure India Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Communicable Diseases Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Communicable Diseases Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim
- PRICE
-
$3280$6560